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Abstract 
This review paper characterizes glass-ceramics con-
taining mica as main crystal phase. The phase formation 
reactions in dependence of the chemical composition and 
the microstructure are shown. Microstructure of mica 
glass-ceramics has been studied by ele..ctron replica and 
scanning electron microscopic (SEM) techniques. 
Mica glass-ceramics have previously been developed 
in Si02-B20rA120rMgO-F--base glasses. The material 
is machinable because of the precipitation of micas of 
fluorophlogopite-type. Also, a machinable glass-ceramic 
for dental applications was developed based on 
KMg2_5(Si40 10)Frmicas. We developed mica glass-cer-
amics in the Si02-Al20rMgO-NaiO-K20-F glass sys-
tem. Phase formation within these glasses was observed 
by SEM. A double controlled nucleation and crystalliza-
tion of mica and apatite crystals was possible in glasses 
of the SiOrMgO-NaiO-K20-F-CaO-P20s-(Al20 3) sys-
tem. The main crystal phases of phlogopite-type were 
characterized by SEM and energy dispersive x-ray spec-
troscopy (EDS) and apatite crystals Ca5(P04)J(OH,F) 
were analyzed by X-ray diffraction measurements. The 
glass-ceramics are useful biomaterials for bone substitu-
tion. EDS analysis shows the ion exchange between 
glass-ceramics and body fluids. The interface reaction 
is characterized by formation of a small phosphate layer, 
and particularly by alkali ion exchange. 
Key Words: Glass-ceramics, mica, apatite, bone substi-
tution, scanning electron microscopy, machinability, 
interface reactions, microstructure, phase formation, 
bioreactivity, ion diffusion. 
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Introduction 
The first machinable glass-ceramic, which contains 
mica as main crystal phase is MACOR® which was de-
veloped by Beall et al. (1971). The composition of the 
base glass is 47.2 Si02, 8.5 B20 3, 16.7 Al20 3, 14.5 
MgO, 9.5 K2 and 6.3 F. 
A special method of controlled nucleation via phase 
separation and crystallization of silicate glasses has been 
used by Beall et al. (1971) to precipitate fluoro-
phlogopite, namely KMg3(AlSi30 10)F2 as main crystal 
phase. The result was a glass ceramic which could be 
machined with standard metal working tools. Because 
of the combination of favorable properties, such as 
machinability and electrical isolation, very interesting 
technological applications can be considered. In order 
to ensure good machinability the precipitated mica crys-
tals in the glass matrix need an optimal size and contact 
with each other. The material is machinable because of 
the preferred cleavage of the micas. Beall (1979) called 
the microstructure of the glass ceramic a "house of cards 
structure", which describes the orientation of the micas 
in the glassy phase. 
Based on this development of Beall et al. (1971) 
further mica glass-ceramics (e.g. , Beall, 1991) have 
been developed also for medical applications. The 
authors of the present paper review these developments 
(see chapters "glass-ceramic of DICOR®-type", 
"precipitation of micas rich in ea2+ -ions"). 
Further mica type glass-ceramics for technical pur-
poses have been developed by Vogel et al. (1973) in the 
magnesium-aluminosilicate base glass system. Based on 
these investigations, the authors of this paper developed 
a phlogopite-type glass ceramic for medical application. 
This glass ceramic is biocompatible but not bioactive 
(see chapter "glass-ceramic of BIOVERIT® II-type"). 
The development of bioactive biomaterials has 
strongly been influenced by Hench et al. (1972) who 
developed the biomaterial BIOGLASS® from the SiOi-
NaiO-CaO-P20rF system. The new biomaterials show 
bioactive properties and the materials are bonded to 
living bone. BIOGLASS® forms apatite on the surface 
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Figure 1. Microstructure of DICOR* glass ceramic observed during replica investigation of fracture surface in a 
transmission electron microscope (fEM). Specimen was etched for 5 seconds in 1 % HF. 
Figure 2. SEM of cross-section through globular aggregates of curved phlogopite showing initial stage of crystal-
lization. Polished sample and etched 2.5 seconds in 2 % HF. 
Figure 3. Advanced stage of the precipitation of curved phlogopite crystals. SEM. Polished sample and etched 2.5 
seconds in 2 % HF. 
Figure 4. Curved phlogopite crystals in glass ceramics (BIOVERIT* II-type) having high translucency. SEM. 
Polished sample and etched 2.5 seconds in 2 % HF. 
in contact and reaction with the body fluid and the living 
bone. On the basis of the knowledge of this apatite for-
mation in BIOGLASS*, further bioactive glass-ceramics, 
containing apatite crystals, have been developed 
(Blencke et al., 1977; Strunz et al., 1978). 
Kokubo et al. (1982) showed a preferred bonding of 
bone and apatite-wollastonite glass ceramic, and an addi-
tional apatite formation in reaction with simulated body 
fluid could be shown on the surface of the biomaterial 
(Kokubo et al., 1990). 
The authors of this present paper developed a 
machinable bioactive glass-ceramic consisting of two 
crystal phases, namely mica and apatite, and a glassy 
phase. The microstructure and the properties, especially 
the interphase reactions between mica and bone are pre-
sented (see chapter "BIOVERIT* I-type glass-ceram-
ics"). Other glass-ceramics containing micas and phos-
phates are reviewed (see "glass-ceramics containing 
micas and CaO-, P20s-additives"). 
Glass-Ceramic of DICOR*-Type 
(Mica Glass-Ceramic) 
Grossman (1972, 1983) crystallized glasses consist-
ing essentially of 45-70 % Si~, 8-20 % MgO, 8-15 % 
MgF2, 5-35 % R20 and RO; where R20 consists of 
K20, R~O and C520 and RO consists of SrO or BaO 
and other alkaline earth oxides. Additions, such as 
Zr02, A120 3 and colourants were used. These 
investigations have been the basis for the development of 
a glass of the composition (in weight percent): 60.9 
Si02, 0.6 A120 3, 17.1 MgO, 13.8 K20, 4.9 F, 4.7 
Zr02, 0.05 Ce02 (Adair, 1984). Ce02 can give the 
glass-ceramic fluorescence. This glass was heat treated 
and the microstructure was investigated by scanning 
electron microscopy (SEM) (Grossman, 1989; Adair, 
1984). 
Grossman (1989) showed that the base glass is 
phase separated and mica crystals of KMg2_5Si40u12-
type grow during heat treating the glass from 625 to 
1075 °C. A typical microstructure is shown in Figure 
1 (the preparation technique is indicated in the caption of 
the Figure). The glass ceramic shows excellent proper-
ties, such as machinability, translucency and good bend-
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ing strength. Hence, the material is used in dental 
medicine as crowns. 
Glass-Ceramics of BIOVERIT* II-Type 
(Mica Glass-Ceramic) 
The crystallization behavior of magnesium-alumino-
silicate base glasses was investigated by Vogel et al. 
(1973). N820, K20 and F were added to Si~-Al20r 
MgO-glasses and the mica precipitation has been stud-
ied. Based on these results, Roland et al. (1981) 
analyzed the phase formation processes in glasses of the 
composition: 43-50 Si~, 26-30 Al20 3, 11-15 MgO, 7-
10 R20, 3.3-4.8 F, 0.01-0.6 Cl, 0.1-3 CaO, 0.1-5 
P20 5, wherein R20 is the sum of 3-5.5 wt. % N820 and 
4-6 wt. % K20. A new type of phlogopite in a curved 
shape was precipitated in a glass ceramic. The forma-
tion of this new phlogopite was investigated in a glass 
with the chemical composition (wt. %): 44.5 Si~, 29.9 
Al203, 11.8 MgO, 4.2 F, 4.4 Na2, 4.9 K10, 0.1 Cao, 
0.1 P20 5, 0.1 Cl by TEM and SEM (HOland et al., 
1991a). The chemical composition of this new curved 
mica, (N a0 .18K0 .82)(Mg2_24AI0 .61)(Si2. 78Al1.22) 
010.1of 1.90could be analyzed by energy dispersive spec-
troscopy (EDS) (Roland et al., 1991a). 
In comparison to glasses which form flat mica crys-
tals, the control of the reduced phase separation process 
allowed the formation of the new curved mica crystals 
(HOland et al., 1981). Because of a low concentration 
of nucleating centers, curved micas and cordierite 
crystals (as secondary crystal phase) grow in the range 
700-1050 °C. The phase formation and the structure of 
curved mica crystals, that are typical for glass-ceramics 
ofBIOVERIT* II-type, have been studied in comparison 
to flat crystals (Vogel and ROiand, 1982; Roland et al., 
1983b; Elsen et al. 1989). Crystal structure investiga-
tion by X-ray diffractometry of phlogopite micas showed 
that the curved mica has a still higher content of alumi-
num ions in the octahedral coordination. 
Small glassy phase separated droplets are the nu-
cleating centers of the curved phlogopite. Curved phlo-
gopites grow as isolated ball shaped aggregates (Figure 
2). The crystallization up to 980 °C can be controlled 
so that the curved crystals come into contact with each 
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Figure 9. Interface between bone (guinea pig) and 
mica-apatite glass ceramic (BIOVERIT® I) one year 
after implantation. 
Figure 5. Mica-cordierite glass-ceramic (BIOVERIT® 
II-type). The precipitation of cordierite takes place 
between the curved mica plates. SEM. Polished sample 
and etched 2. 5 seconds in 2 % HF. 
Figure 6. Base glass of mica-apatite glass-ceramic. 
The glass consists of three glassy phases. TEM/replica. 
Fractured surface etched 5 seconds in H Cl. 
Figure 7. Precipitation of Ca5(P04)J(OH,F) apatite 
within the CaO-P20 5-F rich droplet phase. TEM/rep-
lica. Fractured surface etched 5 seconds in HCI. 
Figure 8. Mica.apatite glass-ceramic after one week in 
Ringer's solution. TEM/replica. 
other (Figure 3). The content of crystals within the 
glass-ceramic can be varied, e.g., lowered in compari-
son to Figure 3 and the translucency becomes higher 
(Figure 4). 
Varying the chemical composition, to add more 
MgO and Al20 3 to the melt, it is possible to increase the 
content of the second crystal phase, cordierite (Figure 
5). Therefore, the properties of the glass-ceramic, such 
as translucency, mechanical properties and thermal ex-
pansion coefficient can be controlled depending on the 
particular application in medicine (Roland et al. , 199 la). 
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The experiences of the surgeon (Beleites et al., 
1988) showed that middle ear implants have to have a 
very good machinability, that means a high content of 
curved micas (Beleites et al., 1988) and dental products 
should show a special translucency. 
Precipitation of Micas Rich in Ca2+ -Ions 
Silicate glasses rich in CaO were developed by Ehrt 
and Heidenreich (1978), and Kasuga and Kasuga (1991) . 
A characteristic composition which has been investigated 
by Ehrt and Heidenreich was 50 % SiOi, 18 % A120 3 , 
7 % MgO, 10 % CaO, 3.5 % N310, 4.5 K20, 7 Ma. % 
F. Kasuga and Kasuga (1991) could get glass-ceramics 
of the composition 43 .5 Si02, 12. 7 Al20 3 , 25.5 MgO, 
6.5 CaO, 1.7 K20 and 10. 1 F. The main crystal phase 
is a mica rich in Ca2+ -ions and secondary phases, such 
as diopside, anorthite, richterite and others were pre-
cipitated in the glass-ceramic (Kasuga and Kasuga, 
1991). 
Developments of Ehrt and Heidenreich (1978) and 
Kasuga and Kasuga ( 1991) to increase the Cao-content 
in mica type glass-ceramics had given the possibility to 
develop machinable glass ceramics with high mechanical 
strength (bending strength 210-300 MPa). The micro-
structure of the glass ceramic formed by Kasuga and 
Kasuga contains mica and diopside crystals and a glass 
matrix phase. An application for dental crowns was 
proposed by Kasuga and Kasuga (1991) . 
BIOVERIT® I-Type Glass-Ceramics 
(Mica-Apatite Glass-Ceramics) 
A combination of different properties within a glass 
ceramic material, especially the combination of machina-
bility and bioactivity was possible in multi-component 
glasses of the SiOi-(A120 3)-MgO-NaiO-K20-P--Ca0-
P205 system. Typical compositions are 35.9 Si02, 18.1 
A120 3, 6.5 MgO, 5.1 Na20, 4.0 K20, 16.7 CaO, 11.2 
P20 5 and 2.5 wt. % F_ or 38.7 Si02, 1.4 Al20 3 , 27.7 
MgO, 6.8 K20, 10.4 CaO, 8.2 P20 5 and 1.9 wt. % 
Ti02 (Roland et al., 1983a, Roland et al., 199la). 
Mica-apatite glass-ceramics show a characteristic 
microstructure and phase formation reactions (Vogel and 
Roland, 1987). The base glass shows three glassy 
phases, a Si02-ricb glass matrix, a CaO-P20rF--rich 
big droplet phase, and a Na20-K20-Al20rMgO-P--rich 
b~g droplet phase (Figure 6). Heat treating the glass at 
temperatures between 610 and 1050 °C allowed a double 
controlled in situ crystallization of mica and apatite. 
Apatite grows inside the CaO-P20rF-rich big droplet 
phase (Figure 7) and phlogopite formation is a result of 
a solid state reaction of the glass matrix phase and the 
small droplet phase (Figure 8). The apatite crystals of 
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Ca5(P04)J(OH,F)-type could be determined by X-ray 
diffraction measurements and the flat phlogopitecrystals, 
(Nao.21Ko.s1)(Mgo.52Alo.44)(Si2.8oA11 .20)010.18F 1.s2 
could be analyz.ed by EDS (Holand et al., 1983 a, 
1985). 
The authors of the present paper assume that similar 
reactions take place in glasses containing low concentra-
tions of Al20 3 (or Al20rfree glasses). The difference 
between the phase formation in glasses shown in Figures 
6-8 is that the phases formed are very small and the 
mica consists of KMg2.s(S4010)F2-type. 
Electron microprobe investigations carried out by 
Holand et al. (1991b) show a very good contact of mica-
apatite glass-ceramic and bone. One year after opera-
tion, the reaction interface between bone (tibia of guinea 
pig) and mica-apatite glass-ceramic is less than 15 µm 
(Figures 9 and 10). Apatite is present within the bio-
material but an additional small calcium phosphate layer 
will be formed on the surface of the glass-ceramic. Sec-
ondary ion mass spectroscopy (SIMS) investigations 
show the tendency that phosphate groups become en-
riched at the surface of BIOVERIT* I glass-ceramics 
under simulated conditions (Holand et al., 1991b). 
Figure 11 shows that the peak positions 31, 47 and 63 
are responsible for the enrichment of phosphate groups. 
Additionally an NaCl-rich layer from the simulated body 
fluid seems to be deposited onto the sample (position 35, 
37). 
The process of bioactivity seems to be of a complex 
nature. It includes solid state reactions (apatite-apatite 
reaction), ion diffusion processes (e.g. Na+-, ea2+ -dif-
fusion), Ca-phosphate formation and a possible positive 
influence of silicates (Hench, 1991) on the bone regener-
ation reaction. This corresponds with results of bio-
active behavior of glasses and glass-ceramics reported by 
Hench (1991), Kokubo et al. (1990), and Wilson (1991). 
Gl~-Ceramics Containing Micas 
and Cao, P20 5-Additives 
Shibuya et al. (1990) also formed glasses by adding 
CaO and P20 5 to Si02-(AI20 3)-MgO-K20-F- glasses, 
e.g.: 57.1 SiOi, 11.7 MgO, 13 K20, 5.9 F, 4.8 Zr02, 
3.1 CaO, 2.6 P20 5 and 1.84 Ce02. The formation of 
different crystal phases was investigated by X-ray 
diffraction measurements (Shibuya et al., 1990). 
Shibuya et al. (1990) developed a KMg2.s 
(Si40 10)Frmica glass-ceramic containing also calcium 
phosphate groups. Apatite crystals have been analyz.ed 
by X-ray diffraction measurement after beat treating the 
glass up to 1050-1075 °C. Shibuya et al. (1990) report-
ed also, that they have carried out scanning electron mi-
croscopic measurements which show that the. crystals are 
in close contact with each other, they are cross-linked. 
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Conclusiom 
The results of the authors of papers cited in the bib-
liography and the authors of this paper showed that mica 
glass-ceramics are biocompatible materials which can be 
used for bone substitution in medicine. 
DICOR~-type glass ceramic is used for dental 
restoration. Mica glass-ceramics of BIOVERIT* IT-type 
and mica-apatite glass ceramics of BIOVERIT* I-type 
have been successfully applied in head and neck surgery 
and orthopaedic surgery in more than 600 patients 
(Schubert et al., 1988; Holand et al., 1990). 
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Discussion with Reviewers 
Reviewer III: The paper reviews some material as-
pects of glass-ceramics that are considered by the in-
ventors to be biocompatible. The biological behav-
ior of this type of material is neither investigated, 
nor documented, nor published carefully enough! 
Authors: The biomaterials which have been devel-
oped at Otto-Schott-Institute of Jena University are 
glass-ceramic of BIOVERIT® type. The biocompati-
bility of BIOVERIT® I-type has been investigated by 
J. Gummel, T. Schubert, K.J. Schulze and W. 
Purath and are documented in qualification thesis of 
orthopaedic clinic, Dresden, Germany and partly in 
the text reference Schubert et al., 1988. The bio-
compatibility of BIOVERIT® II-type is shown by E. 
Beleites, University Jena, clinic for otorhino-
laryngology and the results are documented in his 
qualification theses and partly in text reference 
Beleites et al. (1988), and in Vogel and Roland 
(1987). 
The well established cell culture test method was 
utilized for the determination of toxicity for both 
ceramic types. Neither the "bioactive" ceramics nor 
the "bioinert" reference materials demonstrated a 
significant influence on the cellular activity 
(proliferation). 
Additional testing protocols are documented in 
the references listed previously. We have also per-
formed further biocompatibility studies with labora-
tory animals: Sixteen weeks after subcutaneous im-
plantation of Bioverit I, with its higher solubility , a 
stabilization of the cellular reaction was observed. 
The investigators concluded that this result can be 
interpreted as a sign of controlled surface solubility 
factors and excellent biocompatibility. 
